BENLYSTA subst sèche 120 mg flac

7680615320019 CH-61532 L04AG04 07.15.0.

Active substances:

BENLYSTA subst sèche 120 mg flac
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
6153201
CPT
-
Packaging group
1
Unit
Durchstechflasche(n)
Composition
Praeparatio cryodesiccata: belimumabum 120 mg, acidum citricum monohydricum, natrii citras dihydricus, saccharum, polysorbatum 80 pro vitro.

Articles (1)

Benlysta 120 mg, Pulver zur Herstellung einer Infusionslösung
Pulver
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
09/08/2025
Professional SmPC
Français
09/08/2025
Professional SmPC
Italien
09/08/2025

Detailed composition

Substance Quantity Type Category
belimumabum
120.0 MG Substance Wirkstoff (Principe actif)
acidum citricum monohydricum
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
saccharum
- Substance HNIDK
polysorbatum 80
- Substance HNIDK

Reimbursement information

Public price
CHF 186.60
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/05/2015

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
61532
Drug name
Benlysta, Pulver zur Herstellung einer Infusionslösung
Galenic form
PULPA
ATC Code
L04AG04
Authorization status
Z
Dispensation category
A
First authorization
14/06/2012
Authorization expiration date
31/12/9999
IT number
07.15.0.
Domain
Human medicine
Field of application
Systemischer Lupus erythematodes (SLE)

Packaging details

Description (FR)
BENLYSTA subst sèche 120 mg flac
Description (DE)
BENLYSTA Trockensub 120 mg Durchstf
Market launch
14/06/2012
Narcotic (BTM)
No

Other packaging sizes

BENLYSTA subst sèche 400 mg flac
1 DUR
View
Buy us a coffee Explore the data